Picture of OssDsign AB logo

OSSD OssDsign AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: OssDsign: Successful Outcome At 6-Month Follow-Up Of Clinical Study On Sinus Augmentation

Aug 21 (Reuters) - OssDsign AB  OSSD.ST :
    * OSSDSIGN REPORTS SUCCESSFUL OUTCOME AT 6-MONTH FOLLOW-UP
OF
CLINICAL STUDY ON SINUS AUGMENTATION
    * STUDY REPRESENTS FIRST USE OF OSSDSIGN'S PROPRIETARY
CALCIUM
PHOSPHATE MATERIAL IN ORAL CAVITY.
    * GLOBAL MARKET FOR DENTAL MEMBRANES AND BONE GRAFT
SUBSTITUTES AT
$ 620 MILLION IN 2018 ACCORDING TO REPORT BY TRANSPARENCY MARKET
RESEARCH

Source text for Eikon:  ID:nWkr315gdz 
Further company coverage:  OSSD.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on OssDsign AB

See all news